268 related articles for article (PubMed ID: 22867055)
1. Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker.
Chen DY; Chuang HC; Lan JL; Chen YM; Hung WT; Lai KL; Tan TH
BMC Med; 2012 Aug; 10():84. PubMed ID: 22867055
[TBL] [Abstract][Full Text] [Related]
2. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
[TBL] [Abstract][Full Text] [Related]
3. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
6. MAP4K Family Kinases in Immunity and Inflammation.
Chuang HC; Wang X; Tan TH
Adv Immunol; 2016; 129():277-314. PubMed ID: 26791862
[TBL] [Abstract][Full Text] [Related]
7. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
8. AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLK
Chuang HC; Chen YM; Chen MH; Hung WT; Yang HY; Tseng YH; Tan TH
FASEB J; 2019 Oct; 33(10):11469-11480. PubMed ID: 31318609
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
Liu Y; Xia C; Chen J; Fan C; He J
Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.
Liao TL; Chen YM; Hsieh CW; Chen HH; Lee HC; Hung WT; Tang KT; Chen DY
Sci Rep; 2017 Jun; 7(1):4214. PubMed ID: 28646209
[TBL] [Abstract][Full Text] [Related]
11. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
[TBL] [Abstract][Full Text] [Related]
12. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
[TBL] [Abstract][Full Text] [Related]
13. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
Shimojima Y; Ichikawa T; Kishida D; Takamatsu R; Sekijima Y
Clin Exp Immunol; 2021 Nov; 206(2):184-195. PubMed ID: 34319596
[TBL] [Abstract][Full Text] [Related]
14. Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still's disease.
Kim HA; Nam JY; Jung JY; Bae CB; An JM; Jeon JY; Kim BS; Suh CH
Clin Rheumatol; 2014 Jun; 33(6):865-8. PubMed ID: 24770797
[TBL] [Abstract][Full Text] [Related]
15. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
16. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
[TBL] [Abstract][Full Text] [Related]
18. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
19. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
